Ther-Biotic Target B2 by SFI Health (formerly Klaire Labs)

Ther-Biotic Target b2 is a targeted probiotic designed to extend the benefits of breastfeeding. Lactobacillus fermentum has been clinically demonstrated to support breast health and resolve discomfort associated with mammary dysbiosis. As many as one-third of lactating women experience significant discomfort resulting in premature cessation of breastfeeding. Studies have shown that certain lactic acid bacteria species, such as L. fermentum, may prevent and resolve lactation-associated mammary dysbiosis. It is recommended to start supplementation with one capsule of Ther-Biotic Target b2 in the third trimester of pregnancy and continue while nursing to help prevent mammary dysbiosis.